In a sweeping initiative to combat drug-related issues, President Donald Trump has enacted an executive order labeling drug cartels as “foreign terrorist organizations.”
This classification paves the way for possible U.S. military measures, including deploying special forces to target these cartels in Mexico. This strict approach is also shared by the Drug Enforcement Administration (DEA), which has released information on the health risks associated with cannabis use and high levels of THC.
Meanwhile, the Food and Drug Administration (FDA) joins the discourse with warnings about the dangers of using cannabis products during pregnancy.
The FDA strongly advises pregnant women to avoid CBD, THC, and marijuana through warnings disseminated on social media platforms.
In Hawaii, the state Senate maintains a favorable view of marijuana legalization, reflecting the stance of the Senate President, though legislation has stalled in the House in previous sessions.
Contrarily, Kentucky’s Senate, led by the Senate Majority Floor Leader, expresses the Republican Caucus’s disinterest in backing the legalization or decriminalization of marijuana. In Alabama, authorities are looking to eliminate existing medical cannabis cultivation laws, indicating a reversal in policy progression.
Conversely, Minnesota is taking strides toward establishing a legal recreational cannabis industry, as highlighted by the state’s past leading cannabis regulator.
Initiatives at the municipal level are not lagging, with Denver city officials announcing a specialized tax preparation workshop for cannabis social equity licensees. This event is scheduled for Monday, demonstrating ongoing local efforts to aid cannabis entrepreneurs.
International attention towards the cannabis sector is also growing.
The cannabis sector in Saxony, Germany, recently welcomed the state’s Minister President to a cultivation site, signaling a growing international curiosity in the economic potential of cannabis cultivation.
Innovations in cannabis science are ongoing, one recent study suggesting the use of certain core-microbiome species to boost hemp crop growth and possibly influence the plant’s strain-specific characteristics.
Charting the progress and turmoil of cannabis policy and science is Marijuana Moment’s Tom Angell. With rich experience in marijuana policy reportage, Angell brings expertise to the forefront, having managed media communications for groups such as Law Enforcement Against Prohibition and Students for Sensible Drug Policy.
Within the context of this in-depth look at cannabis policy, the keywords “Trump’s AG” and “cannabis questions” intersect with various legal, political, and health dimensions.
These phrases play a crucial role in amplifying the dialogue focusing on the ongoing inquiry and reforms driven by legislative entities regarding cannabis.